Other
2030
Amgen 2030 decreased by 4.3% to $2.20B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.20B to $2.20B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A stable or declining schedule of amortization supports long-term margin expansion.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2030. It provides a m...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_4a0a03Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.20B | $2.20B | $1.70B | $1.70B | $1.80B | $2.10B | $2.10B | $2.10B | $2.90B | $2.90B | $2.90B | $2.20B | $2.30B | $2.30B | $2.20B |
| QoQ Change | — | +0.0% | -22.7% | +0.0% | +5.9% | +16.7% | +0.0% | +0.0% | +38.1% | +0.0% | +0.0% | -24.1% | +4.5% | +0.0% | -4.3% |
| YoY Change | — | — | — | -22.7% | -18.2% | +23.5% | +23.5% | +16.7% | +38.1% | +38.1% | +38.1% | -24.1% | -20.7% | -20.7% | +0.0% |
Range$1.70B – $2.90B
CAGR+0.0%
Avg YoY Growth+6.0%
Median YoY Growth+8.3%
2030 at Other Companies
Frequently Asked Questions
- What is Amgen's 2030?
- Amgen (AMGN) reported 2030 of $2.20B in Q1 2026.
- How has Amgen's 2030 changed year-over-year?
- Amgen's 2030 decreased by 0.0% year-over-year, from $2.20B to $2.20B.
- What does 2030 mean?
- The expected non-cash expense for acquired intangible assets in the year 2030.